Segment Information (Tables)
|
9 Months Ended |
Sep. 30, 2021 |
Segment Reporting [Abstract] |
|
Schedule of reportable business segment information |
Reportable business segment information is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Net sales: |
|
|
|
|
|
|
|
Asia |
$ |
48,417 |
|
|
$ |
38,099 |
|
|
$ |
127,708 |
|
|
$ |
101,814 |
|
Europe |
21,813 |
|
|
18,006 |
|
|
65,468 |
|
|
54,098 |
|
North America |
37,738 |
|
|
37,557 |
|
|
112,872 |
|
|
110,785 |
|
Latin America and Other |
6,778 |
|
|
6,588 |
|
|
20,097 |
|
|
16,765 |
|
Total net sales |
114,746 |
|
|
100,250 |
|
|
326,145 |
|
|
283,462 |
|
|
|
|
|
|
|
|
|
Contribution margin (1): |
|
|
|
|
|
|
|
Asia |
21,421 |
|
|
17,981 |
|
|
55,203 |
|
|
48,560 |
|
Europe |
6,959 |
|
|
5,954 |
|
|
20,343 |
|
|
17,987 |
|
North America |
17,193 |
|
|
12,065 |
|
|
48,892 |
|
|
38,388 |
|
Latin America and Other |
3,961 |
|
|
2,765 |
|
|
11,355 |
|
|
7,161 |
|
Total contribution margin |
49,534 |
|
|
38,765 |
|
|
135,793 |
|
|
112,096 |
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses (2) |
39,528 |
|
|
33,294 |
|
|
108,666 |
|
|
92,863 |
|
Operating income |
10,006 |
|
|
5,471 |
|
|
27,127 |
|
|
19,233 |
|
|
|
|
|
|
|
|
|
Other income (loss), net |
(886) |
|
|
671 |
|
|
(2,290) |
|
|
(230) |
|
Income before provision for income taxes |
$ |
9,120 |
|
|
$ |
6,142 |
|
|
$ |
24,837 |
|
|
$ |
19,003 |
|
_________________________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense. (2) Service fees in China totaled $5.2 million and $11.7 million for the three and nine-month periods ended September 30, 2021, respectively, compared to $3.2 million and $8.0 million for the three and nine-month periods ended September 30, 2020. These service fees are included in selling, general and administrative expenses.
|
Schedule of consolidated net sales revenue by geographical locations |
From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three and nine-month periods ended September 30, 2021 and 2020, as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Net sales: |
|
|
|
|
|
|
|
United States |
$ |
34,960 |
|
|
$ |
35,062 |
|
|
$ |
104,258 |
|
|
$ |
103,048 |
|
South Korea |
15,985 |
|
|
16,592 |
|
|
48,340 |
|
|
47,447 |
|
Other |
63,801 |
|
|
48,596 |
|
|
173,547 |
|
|
132,967 |
|
|
$ |
114,746 |
|
|
$ |
100,250 |
|
|
$ |
326,145 |
|
|
$ |
283,462 |
|
|
Schedule of revenue generated by each of the Company's product lines |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Asia |
|
|
|
|
|
|
|
General health |
$ |
13,150 |
|
|
$ |
10,055 |
|
|
$ |
37,140 |
|
|
$ |
27,364 |
|
Immune |
463 |
|
|
85 |
|
|
1,048 |
|
|
465 |
|
Cardiovascular |
13,018 |
|
|
10,622 |
|
|
35,181 |
|
|
29,284 |
|
Digestive |
10,427 |
|
|
9,935 |
|
|
25,045 |
|
|
24,482 |
|
Personal care |
4,201 |
|
|
2,575 |
|
|
12,015 |
|
|
7,457 |
|
Weight management |
7,158 |
|
|
4,827 |
|
|
17,279 |
|
|
12,762 |
|
|
48,417 |
|
|
38,099 |
|
|
127,708 |
|
|
101,814 |
|
Europe |
|
|
|
|
|
|
|
General health |
$ |
9,308 |
|
|
$ |
7,725 |
|
|
$ |
28,447 |
|
|
$ |
22,501 |
|
Immune |
2,285 |
|
|
1,510 |
|
|
6,119 |
|
|
5,324 |
|
Cardiovascular |
2,774 |
|
|
2,581 |
|
|
8,602 |
|
|
7,693 |
|
Digestive |
5,700 |
|
|
4,541 |
|
|
16,807 |
|
|
13,254 |
|
Personal care |
1,167 |
|
|
1,023 |
|
|
3,592 |
|
|
3,492 |
|
Weight management |
579 |
|
|
626 |
|
|
1,901 |
|
|
1,834 |
|
|
21,813 |
|
|
18,006 |
|
|
65,468 |
|
|
54,098 |
|
North America |
|
|
|
|
|
|
|
General health |
$ |
16,573 |
|
|
$ |
15,839 |
|
|
$ |
49,192 |
|
|
$ |
46,190 |
|
Immune |
5,056 |
|
|
5,790 |
|
|
14,031 |
|
|
18,637 |
|
Cardiovascular |
4,171 |
|
|
4,138 |
|
|
12,406 |
|
|
11,984 |
|
Digestive |
9,079 |
|
|
8,635 |
|
|
28,558 |
|
|
24,734 |
|
Personal care |
1,978 |
|
|
1,963 |
|
|
5,631 |
|
|
5,867 |
|
Weight management |
881 |
|
|
1,192 |
|
|
3,054 |
|
|
3,373 |
|
|
37,738 |
|
|
37,557 |
|
|
112,872 |
|
|
110,785 |
|
Latin America and Other |
|
|
|
|
|
|
|
General health |
$ |
1,959 |
|
|
$ |
2,038 |
|
|
$ |
5,807 |
|
|
$ |
5,002 |
|
Immune |
806 |
|
|
837 |
|
|
2,314 |
|
|
2,326 |
|
Cardiovascular |
448 |
|
|
429 |
|
|
1,351 |
|
|
1,070 |
|
Digestive |
2,941 |
|
|
2,682 |
|
|
8,813 |
|
|
7,008 |
|
Personal care |
406 |
|
|
384 |
|
|
1,149 |
|
|
848 |
|
Weight management |
218 |
|
|
218 |
|
|
663 |
|
|
511 |
|
|
6,778 |
|
|
6,588 |
|
|
20,097 |
|
|
16,765 |
|
|
$ |
114,746 |
|
|
$ |
100,250 |
|
|
$ |
326,145 |
|
|
$ |
283,462 |
|
|
Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2021 |
|
December 31, 2020 |
Property, plant and equipment: |
|
|
|
United States |
$ |
48,176 |
|
|
$ |
50,025 |
|
Other |
4,362 |
|
|
4,330 |
|
Total property, plant and equipment, net |
$ |
52,538 |
|
|
$ |
54,355 |
|
|
Schedule of assets per segment |
Total assets per segment is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2021 |
|
December 31, 2020 |
Assets: |
|
|
|
Asia |
$ |
96,522 |
|
|
$ |
82,572 |
|
Europe |
17,931 |
|
|
16,398 |
|
North America |
117,215 |
|
|
142,324 |
|
Latin America and Other |
8,084 |
|
|
8,204 |
|
Total assets |
$ |
239,752 |
|
|
$ |
249,498 |
|
|